gracecast - leading treatment options for patients with negative tumor pd-l1 nsclc with dr. stephen
Published 3 years ago • 105 plays • Length 6:56Download video MP4
Download video MP3
Similar videos
-
5:58
lung cancer video library - liu - leading treatment options for patients with negative tumor pd l1
-
9:49
gracecast - treatment options for patients with nsclc and high tumor pd-l1 expression
-
6:52
gracecast - lcvl - leading treatment options for patients with low or negative tumor pd-l1 expressio
-
8:39
gracecast - lcvl - leading treatment options for patients with low or negative tumor pd-l1 expressio
-
8:03
gracecast - immunotherapy for small cell lung cancer with dr. stephen liu
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
7:41
gracecast-113_lung-cancer_asco 2012 lc highlights: dr. neal on anti-pd-1 immunotherapy for nsclc
-
5:59
gracecast - are there treatment options for patients with her-2 nsclc
-
9:26
gracecast - lcvl - which patients with advanced nsclc are good candidates for first line immunothera
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
9:19
gracecast-004_lung-cancer_antiangiogenesis in first line nsclc
-
9:18
gracecast - treatment options for metastatic nsclc
-
10:03
gracecast-011_lung-cancer_second line treatment for nsclc
-
40:44
gracecast-050_lung-cancer_ramalingam on first line therapy for advanced nsclc
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe